The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Peptidomimetics—Tailored Enzyme Inhibitors
Abstract
Peptides and proteins (there is no clear boundary between the two classes of compounds) are absolutely essential components of organisms in many ways. While proteins have biocatalytic functions and are important components of tissues, peptides play an important role in the organism as hormones, neurotransmitters, and neuromodulators. Peptides and their analogues have long been used in medicinal chemistry as therapeutic agents for pathological conditions generally characterized by a disruption of the interplay between messenger molecules or enzyme substrates and their targets, the receptors and enzymes. For various biochemical and biophysical reasons there is an increasing tendency towards the use of chemical “Trojan horses” known as peptidomimetics. The chances that such agents are active generally increase with the magnitude of the “deceptive effect”, in other words in proportion to the degree of conversion of a peptide into a non‐peptide. Rational design has become a catchphrase which is at present applied frequently to the development of peptidomimetics. New computer programs are invaluable tools in such design processes. However, in spite of the many advances already made, we are still far from the final goal, the de novo design of peptidomimetics. Rational design is nonetheless advancing rapidly, and it is already clear that developments in the area of peptidomimetics have given a great boost to peptide chemistry as a whole. This can be expected to continue, so that in future peptide chemistry may be characterized by a type of symbiotic alliance between peptides and non‐peptides.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
On the size of the active site in proteases. I. Papain
Schechter, I., & Berger, A. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(67)80055-x · Cited by 5,204
Conformation of Polypeptides and Proteins
Ramachandran, G. N., & Sasisekharan, V. (1968) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60402-7 · Cited by 2,938
Walker, C. H. (1981) · FEBS Letters · doi:10.1016/0014-5793(81)80071-3 · Cited by 2,696
Ondetti, M. A., Rubin, B., & Cushman, D. W. (1977) · Science · doi:10.1126/science.191908 · Cited by 1,856
All ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,799
N-methoxy-n-methylamides as effective acylating agents
Nahm, S., & Weinreb, S. M. (1981) · Tetrahedron Letters · doi:10.1016/s0040-4039(01)91316-4 · Cited by 1,798
A greatly improved procedure for ruthenium tetroxide catalyzed oxidations of organic compounds
Carlsen, P. H. J., Katsuki, T., Martin, V. S., & Sharpless, K. B. (1981) · The Journal of Organic Chemistry · doi:10.1021/jo00332a045 · Cited by 1,597
Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins
Fischer, G., Wittmann-Liebold, B., Lang, K., Kiefhaber, T., & Schmid, F. X. (1989) · Nature · doi:10.1038/337476a0 · Cited by 1,407
Active human immunodeficiency virus protease is required for viral infectivity
Kohl, N. E., Emini, E. A., Schleif, W. A., Davis, L. J., Heimbach, J. C., Dixon, R. A., Scolnick, E. M., & Sigal, I. S. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4686 · Cited by 1,307
Zuckermann, R. N., Kerr, J. M., Kent, S. B. H., & Moos, W. H. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a076 · Cited by 1,277
Serine Proteases: Structure and Mechanism of Catalysis
Kraut, J. (1977) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.46.070177.001555 · Cited by 1,245
Conserved Folding in Retroviral Proteases: Crystal Structure of Synthetic HIV-1 Protease
Wlodawer, A., Miller, M., Jaskólski, M., Sathyanarayana, B. K., Baldwin, E., Weber, I. T., Selk, L. M., Clawson, L., Schneider, J., & Kent, S. B. H. (1989) · Science · doi:10.1126/science.2548279 · Cited by 1,168
Interleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Mitsuya, H., & Broder, S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.6.1911 · Cited by 1,039
Peptoids: a modular approach to drug discovery.
Simon, R. J., Kania, R. S., Zuckermann, R. N., Huebner, V. D., Jewell, D. A., Banville, S., Ng, S., Wang, L., Rosenberg, S., & Marlowe, C. K. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9367 · Cited by 953
Rational Design of Peptide-Based HIV Proteinase Inhibitors
Roberts, N. A., Martin, J. A., Kinchington, D., Broadhurst, A. V., Craig, J. C., Duncan, I. B., Galpin, S. A., Handa, B. K., Kay, J., Kröhn, A., et al. (1990) · Science · doi:10.1126/science.2183354 · Cited by 929
Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
Navia, M. A., Fitzgerald, P. M. D., McKeever, B. M., Leu, C.-T., Heimbach, J. C., Herber, W. K., Sigal, I. S., Darke, P. L., & Springer, J. P. (1989) · Nature · doi:10.1038/337615a0 · Cited by 894
Bode, W., Mayr, I., Baumann, U., Huber, R., Stone, S. R., & Hofsteenge, J. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08511.x · Cited by 888
Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin.
Rink, H. (1987) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)96384-6 · Cited by 857
STRUCTURE-BASED INHIBITORS OF HIV-1 PROTEASE
Wlodawer, A., & Erickson, J. W. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002551 · Cited by 833
Peptidomimetics for Receptor Ligands—Discovery, Development, and Medical Perspectives
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199312441 · Cited by 784
The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice
Roques, B. P., Fournié-Zaluski, M. C., Soroca, E., Lecomte, J. M., Malfroy, B., Llorens, C., & Schwartz, J.-C. (1980) · Nature · doi:10.1038/288286a0 · Cited by 705
A new class of angiotensin-converting enzyme inhibitors
Patchett, A. A., Harris, E., Tristram, E. W., Wyvratt, M. J., Wu, M. T., Taub, D., Peterson, E. R., Ikeler, T. J., ten Broeke, J., Payne, L. G., et al. (1980) · Nature · doi:10.1038/288280a0 · Cited by 699
Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells
James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D., & Marsters, J. C. (1993) · Science · doi:10.1126/science.8316834 · Cited by 630
Kinetics of the inhibition of thrombin by hirudin
Stone, S. R., & Hofsteenge, J. (1986) · Biochemistry · doi:10.1021/bi00364a025 · Cited by 586
Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor
Kohl, N. E., Mosser, S. D., deSolms, S. J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, E. M., Oliff, A., & Gibbs, J. B. (1993) · Science · doi:10.1126/science.8316833 · Cited by 579
Ondetti, M. A., Williams, N. J., Sabo, E., Pluscec, J., Weaver, E. R., & Kocy, O. (1971) · Biochemistry · doi:10.1021/bi00798a004 · Cited by 521
Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom
Ferreira, S. H., Bartelt, D. C., & Greene, L. J. (1970) · Biochemistry · doi:10.1021/bi00815a005 · Cited by 513
Strategies for antiviral therapy in AIDS
Mitsuya, H., & Broder, S. (1987) · Nature · doi:10.1038/325773a0 · Cited by 487
Walker, F. J., Sexton, P. W., & Esmon, C. T. (1979) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(79)90103-7 · Cited by 475
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
Maraganore, J. M., Bourdon, P., Jablonski, J., Ramachandran, K. L., & Fenton, J. W. (1990) · Biochemistry · doi:10.1021/bi00482a021 · Cited by 466
Riordan, J. (2002) · Encyclopedia of Molecular Biology · doi:10.1002/047120918x.emb1241 · Cited by 456
Sweet, R. M., Wright, H. T., Janin, J., Chothia, C. H., & Blow, D. M. (1974) · Biochemistry · doi:10.1021/bi00717a024 · Cited by 433
Schechter, I., & Berger, A. (1968) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(68)90326-4 · Cited by 415
HIV protease: a novel chemotherapeutic target for AIDS
Huff, J. R. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00112a001 · Cited by 409
Willumsen, B. M., Norris, K., Papageorge, A. G., Hubbert, N. L., & Lowy, D. R. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02177.x · Cited by 399
Probing Immunosuppressant Action with a Nonnatural Immunophilin Ligand
Bierer, B. E., Somers, P. K., Wandless, T. J., Burakoff, S. J., & Schreiber, S. L. (1990) · Science · doi:10.1126/science.1700475 · Cited by 352
Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.
Evans, B. E., Bock, M. G., Rittle, K. E., DiPardo, R. M., Whitter, W. L., Veber, D. F., Anderson, P. S., & Freidinger, R. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4918 · Cited by 327
Banner, D. W., & Hadváry, P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54894-8 · Cited by 325
Freidinger, R. M., Veber, D. F., Perlow, D. S., Brooks, J. R., & Saperstein, R. (1980) · Science · doi:10.1126/science.7001627 · Cited by 315
Peptidyl‐Prolyl cis/trans Isomerases and Their Effectors
Fischer, G. (1994) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199414151 · Cited by 308
Suguna, K., Padlan, E. A., Smith, C. W., Carlson, W. D., & Davies, D. R. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7009 · Cited by 307
Murachi, T. (1983) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(83)90165-2 · Cited by 302
Kettner, C. A., & Shenvi, A. B. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42521-x · Cited by 294
Multiple Peptide Synthesis Methods and Their Applications. New Synthetic Methods (87)
Jung, G., & Beck‐Sickinger, A. G. (1992) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199203673 · Cited by 292
HTLV-III gag Protein Is Processed in Yeast Cells by the Virus pol -Protease
Kramer, R. A., Schaber, M. D., Skalka, A. M., Ganguly, K., Wong-Staal, F., & Reddy, E. P. (1986) · Science · doi:10.1126/science.2420008 · Cited by 287
Hirschmann, R. F., Nicolaou, K. C., Pietranico, S., Leahy, E. M., Salvino, J. M., Arison, B., Cichy, M. A., Spoors, P. G., & Shakespeare, W. C. (1993) · Journal of the American Chemical Society · doi:10.1021/ja00079a039 · Cited by 272
Hanson, S. R., & Harker, L. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.9.3184 · Cited by 265
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs, J. B., Pompliano, D. L., Mosser, S. D., Rands, E., Lingham, R. B., Singh, S. B., Scolnick, E. M., Kohl, N. E., & Oliff, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52998-7 · Cited by 260
The selective inhibition of thrombin by peptides of boroarginine.
Kettner, C., Mersinger, L., & Knabb, R. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44751-x · Cited by 254
Recent developments in the design of angiotensin‐converting enzyme inhibitors
Wyvratt, M. J., & Patchett, A. A. (1985) · Medicinal Research Reviews · doi:10.1002/med.2610050405 · Cited by 253
Hangauer, D. G., Monzingo, A. F., & Matthews, B. W. (1984) · Biochemistry · doi:10.1021/bi00319a011 · Cited by 247
Steady-state kinetic mechanism of ras farnesyl:protein transferase
Pompliano, D. L., Rands, E., Schaber, M. D., Mosser, S. D., Anthony, N. J., & Gibbs, J. B. (1992) · Biochemistry · doi:10.1021/bi00130a010 · Cited by 246
Duncia, J. V., Chiu, A. T., Carini, D. J., Gregory, G. B., Johnson, A. L., Price, W. A., Wells, G. J., Wong, P. C., Calabrese, J. C., & Timmermans, P. B. M. W. M. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00167a007 · Cited by 241
Medicinal Chemistry in the Golden Age of Biology: Lessons from Steroid and Peptide Research
Hirschmann, R. (1991) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199112781 · Cited by 228
A dozen years of retro-inverso peptidomimetics
Chorev, M., & Goodman, M. (1993) · Accounts of Chemical Research · doi:10.1021/ar00029a007 · Cited by 226
Computer design of bioactive molecules: A method for receptor‐based de novo ligand design
Moon, J. B., & Howe, W. J. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110409 · Cited by 223
Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
Garcia, A. M., Rowell, C., Ackermann, K., Kowalczyk, J. J., & Lewis, M. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46638-5 · Cited by 220
Peptidomimetics derived from natural products
Wiley, R. A., & Rich, D. H. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130305 · Cited by 217
Synthetic Inhibitors of Elastase
Edwards, P. D., & Bernstein, P. R. (1994) · Medicinal Research Reviews · doi:10.1002/med.2610140202 · Cited by 213
Low-Molecular-Weight Enzyme Inhibitors of Microbial Origin
Umezawa, H. (1982) · Annual Review of Microbiology · doi:10.1146/annurev.mi.36.100182.000451 · Cited by 202
Dreyer, G. B., Metcalf, B. W., Tomaszek, T. A., Carr, T. J., Chandler, A. C., Hyland, L., Fakhoury, S. A., Magaard, V. W., Moore, M. L., & Strickler, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.9752 · Cited by 201
Binding of the by-product analog benzylsuccinic acid by carboxypeptidase A
Byers, L. D., & Wolfenden, R. (1973) · Biochemistry · doi:10.1021/bi00735a008 · Cited by 195
EFFECTS OF UK 69 578: A NOVEL ATRIOPEPTIDASE INHIBITOR
Northridge, D., Alabaster, C., Connell, J. C., Dilly, S., Lever, A., Jardine, A., Barclay, P., Dargie, H., Findlay, I., & Samuels, G. R. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90714-9 · Cited by 193
Low molecular weight, non-peptide fibrinogen receptor antagonists
Alig, L., Edenhofer, A., Hadvary, P., Huerzeler, M., Knopp, D., Mueller, M., Steiner, B., Trzeciak, A., & Weller, T. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a017 · Cited by 190
Liskamp, R. M. J. (1994) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19941130102 · Cited by 188
Endothelin and the production of cerebral vasospasm in dogs
Asano, T., Ikegaki, I., Suzuki, Y., Satoh, S.-I., & Shibuya, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92258-4 · Cited by 187
Nonfarnesylated tetrapeptide inhibitors of protein farnesyltransferase
Goldstein, J. L., Brown, M. S., Stradley, S. J., Reiss, Y., & Gierasch, L. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98441-3 · Cited by 185
Catalysis of protein folding by cyclophilins from different species
Schönbrunner, E. R., Mayer, S., Tropschug, M., Fischer, G., Takahashi, N., & Schmid, F. X. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67841-5 · Cited by 181
A hierarchical approach to peptidomimetic design
Marshall, G. R. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)90214-5 · Cited by 175
Peptidmimetica für Rezeptorliganden – Entdeckung, Entwicklung und medizinische Perspektiven
Giannis, A., & Kolter, T. (1993) · Angewandte Chemie · doi:10.1002/ange.19931050905 · Cited by 168
McMahon, E. G., Palomo, M. A., Moore, W. M., McDonald, J. F., & Stern, M. K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.703 · Cited by 165
Doherty, A. M. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00087a001 · Cited by 154
Smith, A. B., Keenan, T. P., Holcomb, R. C., Sprengeler, P. A., Guzman, M. C., Wood, J. L., Carroll, P. J., & Hirschmann, R. F. (1992) · Journal of the American Chemical Society · doi:10.1021/ja00052a093 · Cited by 136
Rich, D. H., Sun, C. Q., Prasad, J. V. N. V., et al. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00107a049 · Cited by 126
Meek, T. D. (1992) · Journal of enzyme inhibition · doi:10.3109/14756369209041357 · Cited by 126
Bode, W., Türk, V., & Stürzebecher, J. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb19320.x · Cited by 124
Evans, B., Rittle, K. E., Homnick, C. F., Springer, J. P., Hirshfield, J. M., & Veber, D. F. (1985) · The Journal of Organic Chemistry · doi:10.1021/jo00223a037 · Cited by 118
Peptide Secondary Structure Mimetics: Recent Advances and Future Challenges
Kahn, M. (1993) · Synlett · doi:10.1055/s-1993-22619 · Cited by 109
Altschuh, D., Vix, O., Rees, B., & Thierry, J. (1992) · Science · doi:10.1126/science.1566062 · Cited by 106
Martin, S. F., Austin, R. E., Oalmann, C. J., Baker, W. R., Condon, S. L., DeLara, E., Rosenberg, S. H., Spina, K. P., Stein, H. H., & Cohen, J. B. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00088a005 · Cited by 103
Conformationally constrained nonpeptide β-turn mimetics of enkephalin
Gardner, B., Nakanishi, H., & Kahn, M. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)90205-4 · Cited by 102
Case histories of peptidomimetics: Progression from peptides to drugs
Adang, A. E. P., Hermkens, P. H. H., Linders, J. T. M., Ottenheijm, H. C. J., & van Staveren, C. J. (1994) · Recueil des Travaux Chimiques des Pays-Bas · doi:10.1002/recl.19941130202 · Cited by 100
Protein β-turn mimetics I. Design, synthesis, and evaluation in model cyclic peptides.
Ripka, W. C., Lucca, G. V. D., Bach, A., Pottorf, R. S., & Blaney, J. M. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)90217-0 · Cited by 99
Oleksyszyn, J., Boduszek, B., Kam, C.-M., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00028a004 · Cited by 99
Peptoids—A New Approach to the Development of Pharmaceuticals
Kessler, H. (1993) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199305431 · Cited by 97
The Design and Properties of N‐Carboxyalkyldipeptide Inhibitors of Angiotensin‐Converting Enzyme
Patchett, A. A., & Cordes, E. H. (1985) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123034.ch1 · Cited by 95
Cysteine protease inhibition by azapeptide esters
Magrath, J., & Abeles, R. H. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00101a004 · Cited by 94
Llorens‐Cortés, C., Gacel, G., Swerts, J.-P., Perdrisot, R., Fournié‐Zaluski, M., Schwartz, J.-C., & Roques, B. P. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(80)91371-6 · Cited by 93
A Potent Reversible Inhibitor of Carboxypeptidase A
Byers, L. D., & Wolfenden, R. V. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45746-3 · Cited by 91
Williams, P. D., Anderson, P., Ball, R. G., Bock, M. G., Carroll, L., Chiu, S.-H. L., Clineschmidt, B. V., Culberson, J. C., & Erb, J. M. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00031a004 · Cited by 90
Bone, R. F., Frank, D., Kettner, C. A., & Agard, D. A. (1989) · Biochemistry · doi:10.1021/bi00445a015 · Cited by 88
Fray, A. H., Kaye, R. L., & Kleinman, E. F. (1986) · The Journal of Organic Chemistry · doi:10.1021/jo00375a014 · Cited by 80
Orally active, nonpeptide oxytocin antagonists
Evans, B., Leighton, J. L., Rittle, K. E., Gilbert, K. F., Lundell, G. F., Gould, N. P., Hobbs, D. W., DiPardo, R. M., Veber, D. F., Pettibone, D. J., et al. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00099a020 · Cited by 79
Abdel‐Meguid, S. S., Zhao, B., Murthy, K. H. M., Winborne, E., Choi, J. K., DesJarlais, R. L., Minnich, M. D., Culp, J. S., Debouck, C. M., & Tomaszek, T. A. (1993) · Biochemistry · doi:10.1021/bi00082a019 · Cited by 77
Peptides containing a sulfinamide or a sulfonamide moiety: New transition-state analogues
Moree, W. J., MAREL, G. A. V. D., & Liskamp, R. M. J. (1991) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)92641-8 · Cited by 76
Angiotensin-Converting Enzyme Inhibitors: Biochemical Properties and Biological Action
Ondetti, M. A., Cushman, D. W., & Soffer, R. L. (1984) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238409108720 · Cited by 76
Modifications of the amide bond and conformational constraints in pseudopeptide analogues
Marraud, M., Dupont, V., Grand, V., Zerkout, S., Lecoq, A., BOUSSARD, G., Vidal, J., Collet, A., & Aubry, A. (1993) · Biopolymers · doi:10.1002/bip.360330715 · Cited by 75
Chronic hypertension produced by infusion of endothelin in rats.
Mortensen, L. H., Pawloski, C. M., Kanagy, N. L., & Fink, G. D. (1990) · Hypertension · doi:10.1161/01.hyp.15.6.729 · Cited by 74
Kemp, D. S., Curran, T. P., Davis, W. M., Boyd, J. G., & Muendel, C. C. (1991) · The Journal of Organic Chemistry · doi:10.1021/jo00023a037 · Cited by 70
Amide bond replacements incorporated into CCK-B selective "dipeptoids"
Fincham, C. I., Higginbottom, M., Hill, D. R., Horwell, D. C., O'Toole, J. C., Ratcliffe, G. S., Rees, D. C., & Roberts, E. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00086a017 · Cited by 62
Amide bond isosteres: Imidazolines in pseudopeptide chemistry
Jones, R. C. F., & Ward, G. J. (1988) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)82132-2 · Cited by 58
Hirschmann, R. F. (1991) · Angewandte Chemie · doi:10.1002/ange.19911031008 · Cited by 58
Über Peptidyl‐Prolyl‐cis/trans‐Isomerasen und ihre Effektoren
Fischer, G. S. (1994) · Angewandte Chemie · doi:10.1002/ange.19941061404 · Cited by 54
Inhibitors of Aspartyl Proteinases
Abdel‐Meguid, S. S. (1993) · Medicinal Research Reviews · doi:10.1002/med.2610130605 · Cited by 54
Parallel β-sheet conformation in macrocycles
Wagner, G., & Feigel, M. (1993) · Tetrahedron · doi:10.1016/s0040-4020(01)80237-4 · Cited by 47
LH-RH antagonists: design and synthesis of a novel series of peptidomimetics
De, B., Plattner, J. J., Bush, E. N., Jae, H.-S., Diaz, G. J., Johnson, E. S., & Perun, T. J. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00129a003 · Cited by 45
Design and structure of symmetry-based inhibitors of HIV-1 protease
Erickson, J. W. (1993) · Perspectives in Drug Discovery and Design · doi:10.1007/bf02171658 · Cited by 44
DeSolms, S. J., Giuliani, E. A., Guare, J. P., Vacca, J. P., Sanders, W. M., Graham, S. L., Wiggins, J., Darke, P. L., Sigal, I. S., & Zugay, J. A. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00113a025 · Cited by 40
The design of a new group of angiotensin‐converting enzyme inhibitors
Hassall, C. H., Kröhn, A., Moody, C. J., & Thomas, W. A. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)81036-3 · Cited by 35
Wonacott, A. J., Cooke, R., Hayes, F. R. F., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00073a010 · Cited by 33
Nanomolar-affinity, non-peptide oxytocin receptor antagonists
Evans, B., Lundell, G. F., Gilbert, K. F., Bock, M. G., Rittle, K. E., Carroll, L., Williams, P. D., Pawluczyk, J. M., Leighton, J. L., & Young, M. B. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00077a002 · Cited by 27
Holmes, D. S., Bethell, R. C., Cammack, N. C., et al. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00073a012 · Cited by 24
Conformationally constrained HIV-1 protease inhibitors
Vacca, J. P., Fitzgerald, P. M. D., Holloway, M. K., et al. (1994) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/0960-894x(94)80025-1 · Cited by 22
A synthetic route for the generation of C-7 substituted azepinones
Robl, J. A., & Cimarusti, M. P. (1994) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)76227-7 · Cited by 20
Synthesis and Hypolipidemic Activity of Amine‐Carboxyboranes, and Their Amides and Esters in Rodents
Sood, A., Sood, C. K., Spielvogel, B. F., et al. (1991) · Archiv der Pharmazie · doi:10.1002/ardp.19913240705 · Cited by 14
Vaillancourt, M., Vanasse, B. J., Cohen, É. A., & Sauv�, G. (1993) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)80308-x · Cited by 12
Cited by
Hill, D. J., Mio, M. J., Prince, R. B., Hughes, T. S., & Moore, J. S. (2001) · Chemical Reviews · doi:10.1021/cr990120t · Cited by 2,239
Schafmeister, C. E., Po, J., & Verdine, G. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja000563a · Cited by 1,037
Protease Inhibitors: Current Status and Future Prospects
Leung, D., Abbenante, G., & Fairlie, D. P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990412m · Cited by 883
Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides
Chongsiriwatana, N. P., Patch, J. A., Czyzewski, A. M., Dohm, M. T., Ivankin, A., Gidalevitz, D., Zuckermann, R. N., & Barron, A. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708254105 · Cited by 657
Gentilucci, L., De Marco, R., & Cerisoli, L. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210793292555 · Cited by 586
Metadata
- Authors
- Gante, J.
- Venue
- Angewandte Chemie International Edition in English
- Publisher
- Wiley
- Published
- 1994-09-16
- Volume
- 33
- Issue
- 17
- Pages
- 1699-1720
- ISSN
- 0570-0833 (ISSN-L)
- OpenAlex
- W2136901450
- Cited by
- 825
- References
- 118
- FWCI
- 13.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.